SCHEMBL30289064

SCHEMBL30289064

Cn1c(=O)n(C2CCC(=O)NC2=O)c2ccc(CN3CC(OC4CN(C(=O)OC(C)(C)C)C4)C3)cc21

nearest known ligand 0.54

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ DDB1 Q16531 20/20 0.54
▸ CRBN Q96SW2 20/20 0.54

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26853831 0.95 DDB1 (0.54) DDB1CRBN
SCHEMBL30289396 0.95 DDB1 (0.52) DDB1CRBN
SCHEMBL31003887 0.95 DDB1 (0.54) DDB1CRBN
SCHEMBL23832523 0.90 DDB1 (0.56) DDB1CRBN
SCHEMBL21997585 0.89 CRBN (0.58) DDB1CRBN
SCHEMBL26634910 0.88 DDB1 (0.52) DDB1CRBN
SCHEMBL32672229 0.87 DDB1 (0.56) DDB1CRBN
SCHEMBL32672356 0.87 DDB1 (0.56) DDB1CRBN
SCHEMBL30042453 0.86 DDB1 (0.55) DDB1CRBN
SCHEMBL30733862 0.86 DDB1 (0.57) DDB1CRBN

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4405359-A2 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2024-07-31 — — EP disclosed
WO-2023049790-A2 MDM2 DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. (US) 2023-03-30 — — WO disclosed
Send feedback